We wanted to reassure all our customers that Cherwell Laboratories remains fully operational and is focused on maintaining business as usual, whilst also working hard to minimise the risks for our employees. The ongoing COVID-19 outbreak and new variant is of great concern; however, the promise of mass vaccination offers reassurance for the Spring.
Back in March 2020 we instigated various protective measures such as:
Restricting visitors to site
Increasing availability of hand sanitisers
Introduced additional cleaning around site
Minimised communal area touch points
Regularly sharing information with employees around identifying symptoms
Continued to reinforce the importance of good hygiene practices and social distancing
However, we recognise that COVID-19 will continue to impact our business, staff and communities for some time yet and to mitigate this we continue to:
Deploy home working where possible and practical
Make use of some flexibility within our workforce who are cross trained
Focus on critical tasks
Cancel all non-essential business travel and meetings
Our supply chains appear to be quite robust and ongoing dialogue with many of our key suppliers has confirmed that they have robust contingency plans in place. We recognise we are a small piece in an important supply chain which ultimately serves patients and our existing continuity planning had already identified actions we can take, such as ensuring we retain suitable stock reserves of critical raw materials and finished goods.
We will continue to follow government advice and use this information to update our contingency planning and actions. Please do not hesitate to contact us if you have any questions or concerns regarding supply of products.
Growth Promotion Testing: A Guide to Good Practices
Get an in-depth understanding of key considerations and best practices when undertaking growth promotion testing (GPT).
This also guide includes why and how GPT is performed, frequently asked questions and useful references.